Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kinan Alhallak

Showing results (11-20 of 24) with videos related to

Pageof 3
Sort By:
Scientific Reports|June 13, 2018
A Radiosensitizing Inhibitor of HIF-1 alters the Optical Redox State of Human Lung Cancer Cells In VitroDavid E Lee, Kinan Alhallak, Samir V Jenkins, et al.
Leukemia|January 22, 2021
Nanoparticle T-cell engagers as a modular platform for cancer immunotherapyKinan Alhallak, Jennifer Sun, Katherine Wasden, et al.
Scientific Reports|September 30, 2021
A pilot study of 3D tissue-engineered bone marrow culture as a tool to predict patient response to therapy in multiple myelomaKinan Alhallak, Amanda Jeske, Pilar de la Puente, et al.
Oncotarget|September 22, 2021
Nanoparticle T cell engagers for the treatment of acute myeloid leukemiaKinan Alhallak, Jennifer Sun, Barbara Muz, et al.
International Journal of Radiation Oncology, Biology, Physics|November 30, 2020
Localized Delivery of Cisplatin to Cervical Cancer Improves Its Therapeutic Efficacy and Minimizes Its Side Effect ProfileCinzia Federico, Jennifer Sun, Barbara Muz, et al.
Immunology|February 16, 2024
Pla2g5 contributes to viral-like-induced lung inflammation through macrophage proliferation and LA/Ffar1 lung cell recruitmentMasaya Koganesawa, Daniel F Dwyer, Kinan Alhallak, et al.
Cancers|February 5, 2020
Targeting CD47 as a Novel Immunotherapy for Multiple MyelomaJennifer Sun, Barbara Muz, Kinan Alhallak, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 9, 2025
Platelets engage mast cells in a bilateral IL-33-driven feed-forward loopAiri Nishida, Jun Nagai, Madeline Hastings, et al.
The Journal of Allergy and Clinical Immunology|January 23, 2026
Platelet-macrophage cooperation drives IL-33-dependent type 2 lung immunopathology in a sex-biased mannerHiroaki Hayashi, Jun Nagai, Juying Lai, et al.
Leukemia & Lymphoma|May 17, 2021
3D tissue engineered plasma cultures support leukemic proliferation and induces drug resistanceKinan Alhallak, Pilar de la Puente, Amanda Jeske, et al.
Pageof 3

Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
Scientific Reports|June 13, 2018
A Radiosensitizing Inhibitor of HIF-1 alters the Optical Redox State of Human Lung Cancer Cells In VitroDavid E Lee, Kinan Alhallak, Samir V Jenkins, et al.
Leukemia|January 22, 2021
Nanoparticle T-cell engagers as a modular platform for cancer immunotherapyKinan Alhallak, Jennifer Sun, Katherine Wasden, et al.
Scientific Reports|September 30, 2021
A pilot study of 3D tissue-engineered bone marrow culture as a tool to predict patient response to therapy in multiple myelomaKinan Alhallak, Amanda Jeske, Pilar de la Puente, et al.
Oncotarget|September 22, 2021
Nanoparticle T cell engagers for the treatment of acute myeloid leukemiaKinan Alhallak, Jennifer Sun, Barbara Muz, et al.
International Journal of Radiation Oncology, Biology, Physics|November 30, 2020
Localized Delivery of Cisplatin to Cervical Cancer Improves Its Therapeutic Efficacy and Minimizes Its Side Effect ProfileCinzia Federico, Jennifer Sun, Barbara Muz, et al.
Immunology|February 16, 2024
Pla2g5 contributes to viral-like-induced lung inflammation through macrophage proliferation and LA/Ffar1 lung cell recruitmentMasaya Koganesawa, Daniel F Dwyer, Kinan Alhallak, et al.
Cancers|February 5, 2020
Targeting CD47 as a Novel Immunotherapy for Multiple MyelomaJennifer Sun, Barbara Muz, Kinan Alhallak, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 9, 2025
Platelets engage mast cells in a bilateral IL-33-driven feed-forward loopAiri Nishida, Jun Nagai, Madeline Hastings, et al.
The Journal of Allergy and Clinical Immunology|January 23, 2026
Platelet-macrophage cooperation drives IL-33-dependent type 2 lung immunopathology in a sex-biased mannerHiroaki Hayashi, Jun Nagai, Juying Lai, et al.
Leukemia & Lymphoma|May 17, 2021
3D tissue engineered plasma cultures support leukemic proliferation and induces drug resistanceKinan Alhallak, Pilar de la Puente, Amanda Jeske, et al.
Pageof 3